Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle A Lally

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
AIDS Care|March 11, 2017
A genetic marker of risk in HIV-infected individuals with a history of hazardous drinkingDavid H Barker, Nicole R Nugent, Jeanne R Delgado, et al.
AIDS Patient Care and Stds|February 1, 2007
Feasibility and acceptability of rapid HIV testing in jailCurt G Beckwith, Sarah Atunah-Jay, Jonathan Cohen, et al.
The American Journal of Medicine|April 12, 2003
A review of the case for hepatitis B vaccination of high-risk adultsJosiah D Rich, Catherine G Ching, Michelle A Lally, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 13, 2017
Partner Notification for Youth Living With HIV in 14 Cities in the United StatesJacob J van den Berg, Marjan Javanbakht, Pamina M Gorbach, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 15, 2020
Transmission Risk Among Youth Living With HIV in the U.SJacob J van den Berg, Kristi E Gamarel, Andrew O Westfall, et al.
The Journal of Clinical Investigation|July 26, 2016
Stem-loop binding protein is a multifaceted cellular regulator of HIV-1 replicationMing Li, Lynne D Tucker, John M Asara, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
HIV Continuum of Care for Youth in the United StatesMichelle A Lally, Jacob J van den Berg, Andrew O Westfall, et al.
The Journal of Infectious Diseases|April 1, 2011
A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteersPaul Spearman, Michelle A Lally, Marnie Elizaga, et al.
Journal of Clinical Microbiology|March 8, 2019
Impact of Early Antiretroviral Therapy on Detection of Cell-Associated HIV-1 Nucleic Acid in Blood by the Roche Cobas TaqMan TestLinda L Jagodzinski, Mark M Manak, Holly R Hack, et al.
AIDS Research and Human Retroviruses|December 26, 2008
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adultsClayton D Harro, Michael N Robertson, Michelle A Lally, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
AIDS Care|March 11, 2017
A genetic marker of risk in HIV-infected individuals with a history of hazardous drinkingDavid H Barker, Nicole R Nugent, Jeanne R Delgado, et al.
AIDS Patient Care and Stds|February 1, 2007
Feasibility and acceptability of rapid HIV testing in jailCurt G Beckwith, Sarah Atunah-Jay, Jonathan Cohen, et al.
The American Journal of Medicine|April 12, 2003
A review of the case for hepatitis B vaccination of high-risk adultsJosiah D Rich, Catherine G Ching, Michelle A Lally, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 13, 2017
Partner Notification for Youth Living With HIV in 14 Cities in the United StatesJacob J van den Berg, Marjan Javanbakht, Pamina M Gorbach, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 15, 2020
Transmission Risk Among Youth Living With HIV in the U.SJacob J van den Berg, Kristi E Gamarel, Andrew O Westfall, et al.
The Journal of Clinical Investigation|July 26, 2016
Stem-loop binding protein is a multifaceted cellular regulator of HIV-1 replicationMing Li, Lynne D Tucker, John M Asara, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
HIV Continuum of Care for Youth in the United StatesMichelle A Lally, Jacob J van den Berg, Andrew O Westfall, et al.
The Journal of Infectious Diseases|April 1, 2011
A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteersPaul Spearman, Michelle A Lally, Marnie Elizaga, et al.
Journal of Clinical Microbiology|March 8, 2019
Impact of Early Antiretroviral Therapy on Detection of Cell-Associated HIV-1 Nucleic Acid in Blood by the Roche Cobas TaqMan TestLinda L Jagodzinski, Mark M Manak, Holly R Hack, et al.
AIDS Research and Human Retroviruses|December 26, 2008
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adultsClayton D Harro, Michael N Robertson, Michelle A Lally, et al.
Pageof 4